Acepodia Raises $109M in Series C Financing
The company will use the funding to advance its pipeline of off-the-shelf cell therapies, including its lead candidate being studied in HER2-expressing solid tumors.
Source: precisiononcologynews.com
Bioengine Venture News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bioengine Venture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bioengine Venture Today - Breaking & Trending Today